Oncology Nurses Quality Improvement Series 
Track 3: Immune Checkpoint Inhibitors: The Oncology Nurse’s Role in the Monitoring and Early Intervention of Immune-related Adverse Events
Track 4: Updates for Oncology Nurses—Optimizing the Paradigm Shift Driven by CDK 4/6 Inhibitors in Metastatic HR-Positive, HER2-Negative Breast Cancer

Exit Survey
Questions marked with a * are required
18%
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Are you an oncology certified nurse (OCN)?
Date of meeting
Powered by QuestionPro